| JXSL1200068 | 注射用Intetumumab单抗 | intetumumab | Lyophilized | Biological Products | Import Drug Application | 2012-11-12 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2014-07-31 | view |
| CXHL1301260 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301261 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301262 | BGB-283 | lifirafenib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301259 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1401941 | BGB-3111 | zanubrutinib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1401948 | BGB-3111胶囊 | zanubrutinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1401942 | BGB-3111胶囊 | zanubrutinib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-02-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-03-11 | view |
| CXHL1501851 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501850 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501849 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501848 | BGB-290 | pamiparib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501852 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| JYHB1800296 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | Supplementary Application | 2018-03-13 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-03-27 | view |
| JYHZ1800113 | 注射用紫杉醇（白蛋白结合型） | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs | License Renew | 2018-04-27 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2018-09-30 | view |
| JYHB1800601 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-25 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-06-07 | view |
| JYHB1800600 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-25 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-06-07 | view |
| JYHB1800603 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-25 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-06-07 | view |
| JYHB1800602 | 来那度胺胶囊 | lenalidomide | Capsule | Chemical Drugs | Supplementary Application | 2018-05-25 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2018-06-07 | view |
| JXHL1800061 | 注射用紫杉醇(白蛋白结合型) | paclitaxel(albumin bound) | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2018-06-11 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2018-08-14 | view |
